Vaccines: Ema confirms safety, extremely rare serious effects

The vaccines authorized in the EU are effective, their safety is continuously monitored and evaluated, and the vast majority of known side effects are mild and short-lived. Serious problems are “extremely rare”. This is confirmed by the European Medicines Agency by publishing updated data on the safety of anti-Covid vaccines, with the total doses administered for each vaccine and the number of suspected side effects, i.e. medical events that have been observed and reported after vaccination, but that are not necessarily related to or caused by the vaccine.
At the end of January 2022, Ema indicates, a total of about 797 million doses were administered in the EU and in the European Economic Area (SEE). For Pfizer-BioNTech, 570 million doses were administered, with 582,074 reports of suspected side effects. AstraZeneca vaccine doses were 69 million, with 244,603 suspected side effects.
For Moderna, the administrations were 139 million, with 150,807 suspected cases. Out of 19 million Janssen doses, there were 40,766 reports. Data on Novavax, authorized in December, is not yet available.

Source: Ansa

Share this article:

Leave a Reply

most popular